Zealand Pharma issues correction on share buy-back program trades (week 35)
Zealand Pharma A/S (NASDAQ:ZEAL) issued a company announcement correction covering transactions related to its share buy-back program for week 35, 2026.
Company announcement No.
45 / 2026Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)Copenhagen, Denmark, September 2, 2026 — Zealand Pharma A/S ("the Company" or “Zealand Pharma”) NASDAQ:ZEAL (CVR-no.
20045078), a biotechnology company transforming the futur…